Massachusetts regulators proposed a formal reprimand for a company now linked to deadly fungal meningitis outbreak that has hit Ohio and several other states.
But The Associated Press reports they never delivered it after the company said in 2004 the reprimand could be fatal to its business. The sanction by the Board of Registration in Pharmacy was included in a proposed consent decree to resolve complaints against the New England Compounding Center. The complaints included a failure to meet accepted standards for making the same steroid that's been connected to an outbreak that's killed 24 people and sickened 293 others. The case ended without disciplinary action as part of a different consent agreement reached in 2006.